World News Insights
1-3 Minute Gist

All Topics Group

Novartis is developing a whole new system for developing pharmaceutical treatments by putting medical science at the centre of things.

12/11/2007

Novartis' CEO Vasella, and Dr Fishman who heads the global research labs in Cambridge, Massachusetts, are redoing the way the company develops drugs and runs the company. Senior leaders are now medically trained scientists, and Novartis has shed much of the old marketing and sales staff. Drug discovery focusses on Dr. Fishman's approach to go after common molecular pathways and develop medicines for diseases that may be rare, but reveal the knowledge behind addressing all diseases that have that common underlying molecular pathway as the source of the diseases functioning.

Grouped Articles

Novartis Chairman Stresses Need for R&D Investment

Wall Street Journal 03.22.2014

Novartis Plans Restructuring

Wall Street Journal 12.11.2007

Translating Genes to Drugs

Wall Street Journal 12.17.2007

Big Drug R&D on Campus

BusinessWeek 05.08.2008

CEO Gambles on a Novartis Makeover

Wall Street Journal 05.20.2008

Outsourcing the Drug Industry

BusinessWeek 09.04.2008

Overhaul Spurs Novartis Labs

Wall Street Journal 11.20.2008

Novartis: Radically Remaking Its Drug Business

BusinessWeek 06.11.2009

Seeking a Shorter Path to New Drugs

New York Times 11.15.2009

Glaxo Tries Biotech Model to Spur Drug Innovations

Wall Street Journal 07.01.2010

Novartis: Strategy on Track

Wall Street Journal 09.13.2011

Novartis Retools Brain Work

Wall Street Journal 12.08.2011

Novartis and Penn Unite On Anticancer Approach

New York Times 08.06.2012

Drug Companies Face Political, Scientific Attacks

Wall Street Journal 01.23.2008

Builder of Novartis Is Stepping Down

Wall Street Journal 01.24.2013


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us